Endologix Appoints Mike Mathias as Chief Commercial Officer
Endologix LLC , a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced the appointment of Mike Mathias as the company’s Chief Commercial Officer, effective immediately.
- Endologix LLC , a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced the appointment of Mike Mathias as the company’s Chief Commercial Officer, effective immediately.
- With a distinguished 30-year career in leading commercial organizations within the cardiovascular arena, Mike brings a wealth of experience and a proven track record of success to Endologix.
- Mike is uniquely qualified to lead our global commercial team and continue the strategic development of our commercial plans.
- In response to his new role, Mike Mathias shared, "Joining Endologix at such a critical juncture is an honor.